Salvage outcomes in patients with first relapse after fludarabine, cyclophosphamide, and rituximab for chronic lymphocytic leukemia: the French intergroup experience.

导出 LinkOut

翻译打印收藏纠错

作者： Luc-Matthieu,Fornecker ^[1] ; Thérèse,Aurran-Schleinitz ^[2] ; Anne-Sophie,Michallet ^[3] ; Bruno,Cazin ^[4] ; Romain,Guieze ^[5] ; Marie-Sarah,Dilhuydy ^[6] ; Jean-Marc,Zini ^[7] ; Cécile,Tomowiak ^[8] ; Stéphane,Lepretre ^[9] ; Florence,Cymbalista ^[10] ; Annie,Brion ^[11] ; Pierre,Feugier ^[12] ; Alain,Delmer ^[13] ; Véronique,Leblond ^[14] ; Loïc,Ysebaert ^[15]

作者单位： Department of Hematology, Hôpitaux Universitaires De Strasbourg, Strasbourg, France. ^[1] Department of Hematology, Institut Paoli-Calmettes, Marseille, France. ^[2] Department of Hematology, Centre Hospitalier Lyon Sud, Hospices Civils De Lyon, Lyon, France. ^[3] Department of Hematology, CHU, Lille, France. ^[4] Department of Hematology, CHU De Clermont-Ferrand, Hôpital Estaing, Université Clermont 1, EA7283, CREaT, Clermont-Ferrand, France. ^[5] Department of Hematology, CHU, Bordeaux, France. ^[6] Department of Hematology, Hôpital Saint-Louis, AP-HP, Paris, France. ^[7] Department of Hematology, CHU, Poitiers, France. ^[8] Department of Hematology, Centre Henri Becquerel, Rouen, France. ^[9] Department of Hematology, Hôpital Avicenne, AP-HP, Bobigny, France. ^[10] Department of Hematology, CHU Jean Minjoz, Besançon, France. ^[11] Department of Hematology, CHU, Nancy, France. ^[12] Department of Hematology, CHU, Reims, France. ^[13] Department of Hematology, Hôpital De La Pitié-Salpétrière, AP-HP, Paris, France. ^[14] Department of Hematology, IUCT-Oncopole, Toulouse, France. ^[15]